Advanced SearchSearch Tips
Intravenous Immunoglobulin Nonresponsive Symptomatic Myocarditis during the Acute Stage of Incomplete Kawasaki Disease
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Pediatric Infection and Vaccine
  • Volume 22, Issue 3,  2015, pp.206-209
  • Publisher : The Korean Society of Pediatric Infectious Diseases
  • DOI : 10.14776/piv.2015.22.3.206
 Title & Authors
Intravenous Immunoglobulin Nonresponsive Symptomatic Myocarditis during the Acute Stage of Incomplete Kawasaki Disease
Sohn, Youngsoo; Kim, Yeo Hyang;
  PDF(new window)
We report the case of a 7-year-old boy who showed treatment-nonresponsive hypotension (59/29 mmHg) and decreased left ventricular systolic function (fractional shortening 22%) in the acute stage of Kawasaki disease (KD). The present case serves to highlight that methylprednisolone pulse therapy should be considered in patients with intravenous immunoglobulin nonresponsive symptomatic myocarditis during the acute stage of KD.
Kawasaki disease;Corticosteroids;Myocarditis;
 Cited by
Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J 2011;9:17. crossref(new window)

Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004;16:508-14. crossref(new window)

Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7. crossref(new window)

Kuwabara M, Yashiro M, Kotani K, Tsuboi S, Ae R, Nakamura Y, et al. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol 2015;25:189-93. crossref(new window)

Aggarwal P, Suri D, Narula N, Manojkumar R, Singh S. Symptomatic myocarditis in Kawasaki disease. Indian J Pediatr 2012;79:813-4. crossref(new window)

Yoshikawa H, Nomura Y, Masuda K, Hazeki D, Yotsumoto K, Arata M, et al. Four cases of Kawasaki syndrome complicated with myocarditis. Circ J 2006;70:202-5. crossref(new window)

Schultheiss HP, Kuhl U, Cooper LT. The management of myocarditis. Eur Heart J 2011;32:2616-25. crossref(new window)

Rosenfeld EA, Shulman ST, Corydon KE, Mason W, Takahashi M, Kuroda C. Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr 1995;26:1000-3.

Singh S, Rohit M, Gupta A, Suri D, Rawat A. Late symptomatic myocarditis in Kawasaki disease: an unusual manifestation. Indian J Pediatr 2014;81:404-5. crossref(new window)

Saneeymehri S, Baker K, So TY. Overview of pharmacological treatment options for pediatric patients with refractory kawasaki disease. J Pediatr Pharmacol Ther 2015;20:163-77.

Fan PC, Chiu CH, Yen MH, Huang YC, Li CC, Lin TY. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003;39:55-7. crossref(new window)